It took us a while to recognize euglycemic diabetic ketoacidosis (euDKA) in patients treated with Na-glucose cotransporter-2 inhibitors. It seems that we may have to be on the lookout for euDKA in patients treated with glucagon-like peptide-1 receptor agonists (#Ozempic #Zepbound)
December 2, 2025 at 10:40 PM
It took us a while to recognize euglycemic diabetic ketoacidosis (euDKA) in patients treated with Na-glucose cotransporter-2 inhibitors. It seems that we may have to be on the lookout for euDKA in patients treated with glucagon-like peptide-1 receptor agonists (#Ozempic #Zepbound)
A Rare Case of Euglycemic Diabetic Ketoacidosis: Triad of Influenza A, Methicillin-Susceptible Staphylococcus aureus Pneumonia, and Sodium-Glucose Co-transporter 2 Inhibitor Use
A Rare Case of Euglycemic Diabetic Ketoacidosis: Triad of Influenza A, Methicillin-Susceptible Staphylococcus aureus Pneumonia, and Sodium-Glucose Co-transporter 2 Inhibitor Use - PubMed
Euglycemic diabetic ketoacidosis (euDKA) is a rare but life-threatening complication of diabetes characterized by ketoacidosis with only mildly elevated or normal blood glucose levels. Sodium-glucose...
t.co
August 27, 2025 at 6:42 PM
A Rare Case of Euglycemic Diabetic Ketoacidosis: Triad of Influenza A, Methicillin-Susceptible Staphylococcus aureus Pneumonia, and Sodium-Glucose Co-transporter 2 Inhibitor Use
@HEFTICM Had one of these last night http://rebelem.com/euglycemic-dka-not-myth/
Euglycemic DKA: It’s not a Myth - REBEL EM - Emergency Me...
Euglycemic DKA (euDKA) is not a Myth: It is essentially D...
rebelem.com
January 27, 2025 at 4:30 PM
@HEFTICM Had one of these last night http://rebelem.com/euglycemic-dka-not-myth/
OniX OnPoint newsletter: Euglycemic Diabetic Ketoacidosis: A Potential Complication of SGLT-2 Inhibitor Treatment www.linkedin.com/pulse/euglyc... via @LinkedIn v
Euglycemic Diabetic Ketoacidosis: A Potential Complication of SGLT-2 Inhibitor Treatment
Summary: A study published in Diabetes Care highlights the association between sodium-glucose cotransporter 2 (SGLT-2) inhibitors and euglycemic diabetic ketoacidosis (euDKA). Key findings include: 13...
www.linkedin.com
December 27, 2024 at 3:40 PM
OniX OnPoint newsletter: Euglycemic Diabetic Ketoacidosis: A Potential Complication of SGLT-2 Inhibitor Treatment www.linkedin.com/pulse/euglyc... via @LinkedIn v
Traditional hospital-based protocols for DKA, in which insulin infusion is adjusted based on glucose levels, are not effective in #euDKA because euglycemia limits the capacity for insulin administration.
How should euDKA be managed?
👉 buff.ly/eKuVKqA
#DiabetesSky #DiabeticKetoacidosis
How should euDKA be managed?
👉 buff.ly/eKuVKqA
#DiabetesSky #DiabeticKetoacidosis
Developing a Protocol for Management of Euglycemic Diabetic Ketoacidosis
Traditional hospital-based protocols for DKA, in which insulin infusion is adjusted based on glucose levels, are not effective in euDKA because euglycemia limits the capacity for insulin…
buff.ly
September 27, 2025 at 3:15 PM
Traditional hospital-based protocols for DKA, in which insulin infusion is adjusted based on glucose levels, are not effective in #euDKA because euglycemia limits the capacity for insulin administration.
How should euDKA be managed?
👉 buff.ly/eKuVKqA
#DiabetesSky #DiabeticKetoacidosis
How should euDKA be managed?
👉 buff.ly/eKuVKqA
#DiabetesSky #DiabeticKetoacidosis
Yes the flozin heart failure trials certainly had large populations without diabetes and found them efficacious (and much, much lower euDKA risk than in patients with diabetes)
November 25, 2024 at 9:07 AM
Yes the flozin heart failure trials certainly had large populations without diabetes and found them efficacious (and much, much lower euDKA risk than in patients with diabetes)